Page last updated: 2024-09-03

neo-gambogic acid and cyclin d1

neo-gambogic acid has been researched along with cyclin d1 in 2 studies

Compound Research Comparison

Studies
(neo-gambogic acid)
Trials
(neo-gambogic acid)
Recent Studies (post-2010)
(neo-gambogic acid)
Studies
(cyclin d1)
Trials
(cyclin d1)
Recent Studies (post-2010) (cyclin d1)
6305910,885705,157

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, H; Fang, N; Li, Q; Peng, D; Su, J; Wang, M; Wang, X; Xia, L; Xu, Q; Yang, L; Zhou, A; Zhu, G1
Gao, J; Han, QB; Ma, L; Wen, ZS; Yu, XJ; Zhou, GB1

Other Studies

2 other study(ies) available for neo-gambogic acid and cyclin d1

ArticleYear
Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:3

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Down-Regulation; Female; Garcinia; Gene Expression Regulation; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Plant Extracts; Resins, Plant; RNA, Messenger; Terpenes; Xanthenes; Xanthones; Xenograft Model Antitumor Assays

2010
Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
    Cancer letters, 2012, Sep-28, Volume: 322, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Autophagy; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Terpenes; TOR Serine-Threonine Kinases; Xanthenes; Xanthones

2012